https://www.businesswire.com/news/home/20180529005641/en/

NEWARK, Calif.--(BUSINESS WIRE)--May 29, 2018--Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and therapeutic conditions, today announced that the Company will participate in the Jefferies 2018 Global Healthcare Conference in New York, NY.

President and Chief Executive Officer, Dan Browne, is scheduled to present on Tuesday, June 5 at 2:00pm ET.